Studies show that IGF-1 may promote the resolution of hyperalgesia, prevent chemotherapy-induced neuropathy and behavioral signs of PDN, reverse neuronal hyperactivity, and elevate the nociceptive threshold. The gene discussed is IGF1; the disease is neuropathy.